(MRNA) Moderna - Performance -73.3% in 12m
Compare MRNA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-36.79%
#59 in Group
Rel. Strength
5.14%
#7247 in Universe
Total Return 12m
-73.25%
#147 in Group
Total Return 5y
-19.98%
#49 in Group
P/E -
(unknown) Percentile in Group
P/E Forward 32.5
77th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -33.81%
(unknown) Percentile in Group
12m Total Return: MRNA (-73.3%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: MRNA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MRNA
| Total Return (including Dividends) | MRNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.42% | -5.85% | -3.01% |
| 3 Months | -34.00% | -11.95% | -3.15% |
| 12 Months | -73.25% | -11.00% | 10.19% |
| 5 Years | -19.98% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | MRNA | XBI | S&P 500 |
| 1 Month | -87.9% | -59.8% | -5.5% |
| 3 Months | -66.2% | -70.5% | -58.4% |
| 12 Months | -93.6% | -6.9% | 84.1% |
| 5 Years | -32.2% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #88 | -2.74% | -5.59% |
| 3 Month | #122 | -25.0% | -31.9% |
| 12 Month | #148 | -69.9% | -75.7% |
| 5 Years | #54 | -20.5% | -65.1% |
FAQs
Does MRNA Moderna outperforms the market?
No,
over the last 12 months MRNA made -73.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months MRNA made -34.00%, while XBI made -11.95%.
Over the last 3 months MRNA made -34.00%, while XBI made -11.95%.
Performance Comparison MRNA vs Indeces and Sectors
MRNA vs. Indices MRNA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.2% | -5.41% | -56.0% | -83.4% |
| US NASDAQ 100 | QQQ | -10.2% | -4.36% | -55.2% | -81.9% |
| US Dow Jones Industrial 30 | DIA | -11.4% | -6.28% | -56.9% | -82.8% |
| German DAX 40 | DAX | -9.92% | -5.04% | -72.8% | -94.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.9% | -8.65% | -40.8% | -82.4% |
| Hongkong Hang Seng | HSI | -13.2% | -11.2% | -46.8% | -90.6% |
| India NIFTY 50 | INDA | -12.3% | -16.3% | -45.6% | -74.0% |
| Brasil Bovespa | EWZ | -11.3% | -16.7% | -48.0% | -61.5% |
MRNA vs. Sectors MRNA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.68% | -4.61% | -64.1% | -92.5% |
| Consumer Discretionary | XLY | -12.0% | -4.59% | -59.3% | -87.3% |
| Consumer Staples | XLP | -14.0% | -6.58% | -56.8% | -84.3% |
| Energy | XLE | -12.3% | -16.4% | -61.6% | -74.1% |
| Financial | XLF | -11.7% | -5.72% | -68.1% | -95.5% |
| Health Care | XLV | -11.6% | -5.26% | -51.3% | -74.9% |
| Industrial | XLI | -11.5% | -7.73% | -55.3% | -81.8% |
| Materials | XLB | -12.3% | -8.93% | -47.9% | -69.3% |
| Real Estate | XLRE | -13.3% | -5.73% | -52.9% | -86.6% |
| Technology | XLK | -10.1% | -4.41% | -50.9% | -75.3% |
| Utilities | XLU | -14.5% | -9.24% | -55.1% | -98.5% |
| Aerospace & Defense | XAR | -10.6% | -9.70% | -59.9% | -94.2% |
| Biotech | XBI | -6.66% | -2.57% | -38.3% | -62.3% |
| Homebuilder | XHB | -11.7% | -8.57% | -36.6% | -65.6% |
| Retail | XRT | -13.5% | -7.92% | -51.9% | -68.5% |